Connected care enters a vital security frontier

Tern plc

As hospitals deploy more connected devices, the real vulnerability is no longer the network but the devices themselves. Device Authority is targeting this exact gap, offering a way to manage trust, identity and compliance at scale, all without manual oversight.

At the heart of the offering is automation of device trust and lifecycle management. For manufacturers and operators of connected medical equipment, the challenge lies in provisioning, rotating, revoking and monitoring credentials across large fleets, often in highly regulated settings. The KeyScaler platform is branded as delivering exactly that: seamless device registration, certificate management, enforcing Zero Trust policy at the edge, and continuous assurance of connected devices. By automating those security operations, the firm aims to reduce human error, accelerate incident response and support compliance across healthcare networks.

The company’s positioning in IoMT complements its broader IoT/OT play, suggesting opportunity for cross‑industry efficiencies. With connected medical devices trending upwards, and hospital networks under increasing pressure to secure them against threat actors and compliance breaches, the addressable market is set to expand.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Talking Medicines targets a growing data need around GLP-1 treatment journeys

Talking Medicines is using GLP-1 discontinuation conversations to show how DrugVoice can help pharmaceutical companies track changing patient needs across the treatment journey.

Device Authority adopts usage-based pricing to support KeyScaler expansion

Device Authority has moved KeyScaler to usage-based pricing, aiming to reduce licensing friction and support broader adoption of its machine identity security platform.

Talking Medicines targets growing demand for GLP-1 patient intelligence

Talking Medicines is using GLP-1 patient conversations to show how behavioural data can help pharmaceutical companies understand changing treatment expectations and engagement.

Talking Medicines builds its AI strategy around specialist life sciences intelligence

Talking Medicines is positioning specialist healthcare intelligence as the core layer that gives agentic AI useful context in life sciences.

Device Authority targets cyber resilience opportunity at TechWorks Summit 2026

Device Authority will focus on continuous IoT and OT compliance, AI and quantum risk at TechWorks Summit 2026 as it strengthens its position in connected-device security.

Talking Medicines builds a more defensible AI model for life sciences

Talking Medicines is combining proprietary healthcare intelligence, AI agents and orchestration to build a more specialised AI platform for life sciences.

Search